Abstract A025: CFON-026, a novel macrocyclic BTK inhibitor disrupts scaffold-dependent signaling and overcomes resistance to BTK-directed therapies
Year: 2026
Type: conference-abstract
Source: Blood Cancer Discovery
Authors: Erica N. Lamkin, Tim Kong, Eduardo Bravo, Allison Cool, Samantha Sekeres, Joost Uitdehaag, Jos de Man, Freek van Cauter, Sander P.W. van Gemert, Yvonne G.T.H. van Mil, Winfried R. Mulder, Michelle Muller, Martine B.W. Prinsen, Jan Gerard Sterrenburg, Diep Vu, Joeri J.P. de Wit, Erik Ensing, Rogier C. Buijsman, Omar Abdel-Wahab, Justin Taylor
Institutions: University of Miami, Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7165800115